1159 - FDG-PET/CT as the superior imaging modality for inflammatory bowel disease (ID 1064) - Society of Nuclear Medicine and Molecular Imaging 2020 Annual Meeting

1159 - FDG-PET/CT as the superior imaging modality for inflammatory bowel disease (ID 1064)

General Clinical Specialties 1159

1159 - FDG-PET/CT as the superior imaging modality for inflammatory bowel disease (ID 1064)

Session Name

Educational Exhibits Poster Session I

Speakers

A. Bhattaru

Authors

Presentation Topic

General Clinical Specialties

Presentation Number

1159

Previous Eposter

541 - Labeled leukocyte Imaging: Improved Leukocyte Isolation with a Novel Automated Microfluidics-Based System (ID 364)

Next Eposters

1149 - Potential applications of FDG-PET/MRI in detecting vascular dementia (ID 1070)

512 - Semi-automatic radiolabeling of insulin-like growth factor-1 protein for the verification of its nose-to-brain delivery by positron emission tomography imaging. (ID 1163)

72 - Objective evaluation of voxelwise partial volume correction methods in brain PET imaging (ID 1188)

232 - Divergent Liver and Brain Levels of 11β-hydroxysteroid Dehydrogenase Type 1 Enzyme in Obesity: Preliminary Results from PET Imaging Studies (ID 39)

1513 - High definition digital photon counting PET for neurology: A phantom-based optimization approach (ID 1154)

1476 - Whole Body Dynamic Perfusion Imaging of Bone Tumors Using Ultra-fast Digital Photon Counting ¹⁸F-NaF PET/CT (ID 206)

3050 - Theranostic Differences Between the United States and the Rest of the World (ID 374)

386 - Novel staggered scintillator configurations for brain TOF-DOI PET detector (ID 1128)

94 - Post therapy SPECT/CT uptake correlates with baseline [¹⁸F]FDG-PET/CT parameters in relapsed non-Hodgkin lymphoma patients treated with [¹⁷⁷Lu]Lu-lilotomab satetraxetan. (ID 1283)

15 - Stimulation-induced cerebellar syndromes in VIM/DRT-DBS: An FDG PET activation study (ID 130)